Product NDC: | 52725-490 |
Proprietary Name: | Fenoglide |
Non Proprietary Name: | fenofibrate |
Active Ingredient(s): | 40 mg/1 & nbsp; fenofibrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52725-490 |
Labeler Name: | Shore Therapeutics, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022118 |
Marketing Category: | NDA |
Start Marketing Date: | 20101118 |
Package NDC: | 52725-490-90 |
Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (52725-490-90) |
NDC Code | 52725-490-90 |
Proprietary Name | Fenoglide |
Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (52725-490-90) |
Product NDC | 52725-490 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fenofibrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101118 |
Marketing Category Name | NDA |
Labeler Name | Shore Therapeutics, Inc |
Substance Name | FENOFIBRATE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |